Thoracic Tumours Register
ConditionThoracic Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSpanish Lung Cancer Group
About this trial
Observational, multicenter study in patients with lung cancer and other thoracic tumors.
The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.
Eligibility criteria
Qualifiers
Patients with thoracic disease, treated with an active treatment or not treated (only palliative care)
Disqualifiers
Patients with other type of tumours
Trial design
Treatments tested in this trial
- Not listed
Trial groups
10,000 Participants
are grouped into 5 trial groupsSponsors and collaborators
Source ClinicalTrials.gov